Skip to main content
BONRAYBIO logo

BONRAYBIO — Investor Relations & Filings

Ticker · 6955 ISIN · TW0006955008 TW Manufacturing
Open in API
Filings indexed 24 across all filing types
Latest filing 2026-05-20 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 6955

About BONRAYBIO

https://www.bonraybio.com

Bonraybio Co., Ltd. specializes in providing comprehensive male infertility solutions through its proprietary LensHooke® brand. The company develops high-precision medical devices and consumables designed to enhance global reproductive healthcare. Its core product portfolio includes automated sperm quality analyzers, sperm DNA fragmentation test kits, and advanced sperm separation systems. Leveraging extensive expertise in medical equipment development, Bonraybio integrates micro-optical technology with artificial intelligence and deep learning algorithms to deliver standardized and efficient diagnostic results. The company achieved a significant milestone by securing FDA clearance for the world's first AI-powered sperm DNA fragmentation test. With a global distribution network spanning over 50 countries, Bonraybio focuses on improving clinical workflows and diagnostic accuracy in the field of male reproductive medicine.

Recent filings

Filing Released Lang Actions
114年度股利金額(股東會決議)
Notice of Dividend Amount Classification · 92% confidence The document is an official announcement by the listed company detailing its dividend distribution policy and amounts (cash dividend per share, sources of reserve distribution, stock dividend ratios, distribution dates, etc.). It provides the specifics of the dividend amount, payment/resolution dates, and related notes, matching the definition of a Notice of Dividend Amount.
2026-05-20 Chinese
公告本公司115年股東常會通過解除董事及其代表人競業禁止
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a regulatory disclosure of the shareholder meeting resolution on lifting non-competition restrictions for directors, including meeting date, vote participation and results. This matches a declaration of voting results at a general meeting (shareholders’ resolution).
2026-05-20 Chinese
公告本公司115年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is a formal announcement of the resolutions passed at the company’s annual general shareholders’ meeting, including approval of earnings distribution, financial statements, capital increases, and procedural amendments. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-05-20 Chinese
115年05月僑外投資持股
Regulatory Filings Classification · 80% confidence The document is a compliance table (“僑外及大陸地區投資人投資持股情形統計表”) filed on the Public Information Observatory site, detailing foreign and mainland China investor holdings before and after a shareholders’ meeting. It is a mandatory regulatory disclosure of shareholding statistics, rather than a financial report, earnings release, proxy statement or major beneficial ownership filing by an individual investor. It falls under general regulatory/compliance announcements that don’t fit another specific category.
2026-05-18 Chinese
115年第1季財務報告書 — 202601_6955_AI1.pdf
Interim / Quarterly Report Classification · 92% confidence The document is titled “合併財務報告暨會計師核閱報告” for the first quarter of fiscal years 115 and 114, and contains full interim financial statements (consolidated balance sheet, income statement, cash flows, notes) along with an auditor’s review report. It covers a quarterly period shorter than a full fiscal year and includes substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report rather than simply an audit report or an announcement. Therefore, it should be classified as an Interim/Quarterly Report. Q1 2026
2026-05-13 Chinese
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 85% confidence The document is from Taiwan’s MOPS (“公開資訊觀測站”) and is titled “115年1季申報作業” (Q1 interim filing). It contains actual financial statement data (equity-method investment balances and period profit/loss) rather than simply announcing availability of a report. Therefore it is part of an interim/quarterly report filing, not merely an announcement or an Excel supplement. Hence it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-13 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.